FarmaTrust, the leader in pharmaceutical supply chain tracking and security, announced in a press release that their FTT token which is a blockchain project that targets pharmaceuticals is listed on Coinbene, the Asian cryptocurrency assets exchange.

The listing on Coinbene, specifically with an ETH/FTT pairing, will promote the trade of the FarmaTrust FTT token, which continues to grow, increasing in demand even in the declining crypto markets. FTT tokens will go into circulation on the Coinbene platform and will ensure that they are available globally.

London based FarmaTrust has been steadily growing since its listing with minor hiccups alongside the market in general, it is being recognized for its fast development and customer engagements. It has also managed to break into the mainstream, with partnerships with Digital Catapult, IMI; as well as customers including SystechOne, Peterson, and governmental entities.

The FTT token is currently ranked 536 on coinmarketcap and in the graph below clearly shows a strong upward momentum despite the decline in global crypto markets.

Blockchain against Fraud The counterfeit medical drugs trade is one of the world’s largest fraud markets, with the World Health Organization estimating that revenues to be around $200 billion. FarmaTrust uses the blockchain to accurately track and trace packages of pharmaceuticals throughout the global supply chain, eliminating the risk of these counterfeit drugs. They provide end-to-end tracking for product data, including chain of identity, tamper alerts, chain of custody, and real-time location reports. Raja Sharif, CEO of FarmaTrust says: “We had said that we would list on Coinbene when the conditions were right for FarmaTrust. Now that our platform is working, and we are bringing on new partners and clients, we will be listing on Coinbene, to allow greater exposure to those interested in FarmaTrust’s future.”

Blockmanity’s Take

FarmaTrust has managed to do the impossible by growing in a declining market. This is pretty impressive and we’ll continue to keep a close eye on them.

Disclaimer: Blockmanity is a news portal and does not provide any financial advice. Blockmanity's role is to inform the cryptocurrency and blockchain community about what's going on in this space. Please do your own due diligence before making any investment. Blockmanity won't be responsible for any loss of funds.

Get the latest news on Blockchain only on Blockmanity.com. Subscribe to us on Google news and do follow us on Twitter @Blockmanity

Did you like the news you just read? Please leave a feedback to help us serve you better